📑 Table of Contents

Hematology thesis topics span the full spectrum of blood disorders — from common iron deficiency anaemia to rare haematological malignancies requiring bone marrow transplant. MD/DM Haematology students have unique research opportunities because blood is easily accessible for sampling, allowing prospective cohort studies, biomarker studies, and treatment outcome analyses. This curated list of 50 research-ready topics will help you identify a feasible, impactful thesis topic for 2026.

1Why Haematology Research Matters in 2026

Blood disorders affect hundreds of millions of people globally, with India carrying a disproportionately large burden of both inherited and acquired haematological conditions. Thalassaemia, sickle cell disease, haemophilia, and iron deficiency anaemia together affect tens of millions of Indians. At the same time, haematological malignancies — leukaemias, lymphomas, and myeloma — are rising in incidence and increasingly treated with novel targeted therapies. Research in this specialty is therefore both clinically urgent and scientifically rich.

Haematology is ideally suited to prospective research because the primary specimen — blood — is easily and repeatedly accessible. This makes serial biomarker studies, treatment response monitoring, and minimal residual disease (MRD) assessments straightforward to conduct. DM Haematology students can enrol patients from day one of diagnosis and follow them longitudinally, generating high-quality outcome data within a 3-year fellowship tenure.

💡 Feasibility Tip

Choose a topic where your unit sees at least 30–50 relevant patients per year. For rare disorders, consider a multi-year retrospective study using your department's haematology register from the past 5 years.

2Anaemias & Red Cell Disorders (1–12)

  1. Iron deficiency anaemia: prevalence, severity, and response to oral vs intravenous iron therapy
  2. Aplastic anaemia: clinico-haematological profile, severity classification, and treatment outcomes (IST vs BMT)
  3. Haemolytic anaemia: aetiology spectrum, Coombs test profile, and treatment outcomes
  4. Thalassaemia major: transfusion requirements, chelation compliance, and iron overload assessment
  5. Sickle cell disease: vaso-occlusive crisis frequency, hydroxyurea response, and quality of life
  6. G6PD deficiency: clinical spectrum, trigger identification, and haematological outcomes
  7. Haemolytic uraemic syndrome: clinical profile, ADAMTS13 activity, and renal outcomes
  8. Paroxysmal nocturnal haemoglobinuria (PNH): clone size, thrombosis risk, and eculizumab outcomes
  9. Hereditary spherocytosis: osmotic fragility, EMA binding test, and splenectomy outcomes
  10. Pernicious anaemia: clinical profile, anti-intrinsic factor antibody positivity, and B12 supplementation outcomes
  11. Diamond-Blackfan anaemia: clinical presentation, steroid response, and transfusion dependence
  12. Anaemia of chronic disease: ferritin/hepcidin levels, correction with treatment of underlying disease
🩸 Need Help?

Need guidance selecting your Haematology thesis topic?

Get FREE expert guidance on topic selection and synopsis writing for MD/DM Haematology. Experts reply within 2 hours!

🔒 100% Confidential · No Spam

3Lymphomas (13–22)

  1. Diffuse large B-cell lymphoma (DLBCL): IPI scoring, R-CHOP response, and 2-year progression-free survival
  2. Hodgkin lymphoma: Ann Arbor staging, ABVD outcomes, and predictors of relapse
  3. Follicular lymphoma: clinical behaviour, transformation rate, and rituximab maintenance outcomes
  4. Mantle cell lymphoma: clinico-pathological features, cyclin D1 expression, and aggressive vs indolent course
  5. T-cell lymphomas: histological subtypes, clinical profile, and outcomes in an Indian cohort
  6. Primary mediastinal B-cell lymphoma: MRI vs CT staging, R-CHOP outcomes, and consolidation radiation
  7. CNS lymphoma: CSF cytology, MRI findings, methotrexate-based regimen outcomes
  8. Burkitt lymphoma in adults: clinical presentation, LDH levels, and intensive chemotherapy outcomes
  9. Mucosa-associated lymphoid tissue (MALT) lymphoma: H. pylori association, antibiotic eradication response, and recurrence
  10. Lymphoma staging: PET-CT vs CT alone — accuracy and impact on treatment decision

4Leukaemias (23–32)

  1. Acute myeloid leukaemia (AML): FAB classification, cytogenetic risk, and induction chemotherapy outcomes
  2. Acute lymphoblastic leukaemia (ALL): EGIL immunophenotyping, MRD assessment, and relapse predictors
  3. Chronic myeloid leukaemia (CML): BCR-ABL levels at 3 and 6 months on imatinib — milestone response rates
  4. Chronic lymphocytic leukaemia (CLL): Rai staging, ZAP-70/CD38 expression, and watch-and-wait vs early treatment
  5. T-cell ALL: clinical profile, steroid sensitivity, and outcomes with BFM protocol
  6. Philadelphia chromosome-positive ALL: imatinib/dasatinib addition to chemotherapy — outcome analysis
  7. Myelodysplastic syndrome (MDS): WHO classification, IPSS-R score, and azacitidine treatment outcomes
  8. Juvenile myelomonocytic leukaemia (JMML): clinical features, RAS mutation profile, and SCT outcomes
  9. Hairy cell leukaemia: clinical profile, bone marrow findings, and cladribine response
  10. Mixed phenotype acute leukaemia (MPAL): diagnostic criteria, lineage assignment, and treatment outcomes
📋 Synopsis Help

Struggling with your Haematology thesis synopsis?

PubMedico writes complete synopses for DM/MD Haematology students — IEC-ready with sample size and methodology.

  • ✓ Free synopsis review (worth ₹2000)
  • ✓ Response in 2 hours
  • ✓ No advance payment

🔒 100% Secure & Confidential

5Bleeding & Coagulation Disorders (33–42)

  1. Immune thrombocytopenic purpura (ITP): clinical spectrum, TPO-RA response, and splenectomy outcomes
  2. Haemophilia A and B: inhibitor development rate, factor concentrate type, and bleed frequency
  3. Von Willebrand disease: subtypes, VWF antigen levels, and desmopressin response
  4. Disseminated intravascular coagulation (DIC): scoring systems (ISTH), aetiology, and mortality predictors
  5. Thrombophilia in young stroke patients: Factor V Leiden, prothrombin mutation, MTHFR prevalence
  6. Thrombophilia in recurrent pregnancy loss: antiphospholipid syndrome prevalence and anticoagulation outcomes
  7. Inherited thrombophilia: protein C, protein S, and antithrombin III deficiency — venous thrombosis risk
  8. Heparin-induced thrombocytopenia (HIT): 4T score performance, anti-PF4 antibodies, and argatroban outcomes
  9. Platelet function disorders: PFA-100 vs aggregometry in diagnosis of inherited platelet disorders
  10. Warfarin monitoring in Indian patients: time in therapeutic range (TTR), bleeding complications, and NOAC comparison

6Bone Marrow & Transplant (43–50)

  1. Allogeneic bone marrow transplant: graft-versus-host disease (GVHD) incidence, grading, and outcome
  2. Autologous stem cell transplant in multiple myeloma: response rates and progression-free survival
  3. Haploidentical BMT: engraftment rate, infection profile, and 1-year survival
  4. Multiple myeloma: ISS staging, proteasome inhibitor response, and minimal residual disease (MRD)
  5. Aplastic anaemia: BMT vs immunosuppressive therapy — a comparative outcome study
  6. Cord blood transplant: engraftment kinetics, outcomes, and graft failure predictors
  7. Myelofibrosis: JAK2/CALR/MPL mutation profile, dynamic IPSS score, and ruxolitinib response
  8. Polycythaemia vera: JAK2 V617F allele burden, thrombosis risk, and cytoreduction outcomes
💡 Pro Tip for DM Haematology Students

For haematological malignancy topics, your institution's haematology register from the past 5 years is a goldmine. Multi-year retrospective studies are feasible and still publishable for rare entities like PNH or hairy cell leukaemia.

❓ Frequently Asked Questions

Quick answers to common questions about DM/MD Haematology thesis topics

Which is the best DM Haematology thesis topic for 2026?+

High-impact areas include MRD monitoring in AML/ALL, JAK inhibitor outcomes in myeloproliferative neoplasms, and T-cell lymphoma characterisation. Choose a topic where your unit sees 20+ relevant patients per year — or use a 5-year retrospective dataset for rare conditions.

What study design suits haematology research best?+

Prospective cohort studies with 12-month follow-up are ideal for treatment outcome topics. Cross-sectional studies work well for prevalence topics (e.g., inhibitor development in haemophilia). Retrospective chart reviews are acceptable for rare malignancies.

How many patients are needed for a haematology thesis?+

For common conditions (e.g., ITP, CML), 60–80 patients prospectively enrolled over 12 months is feasible. For rare conditions (PNH, MPAL), a 5-year retrospective study with 30–50 cases is acceptable and publishable.

Can a DM Haematology student do a systematic review?+

Yes — systematic reviews are accepted by most universities. Topics like "JAK inhibitors in myelofibrosis" or "CAR-T cell therapy in B-ALL" are excellent candidates for systematic review or meta-analysis with PROSPERO registration.

What statistical tests are used most in haematology research?+

Kaplan-Meier curves with log-rank test (survival/remission duration), logistic regression (predictors of response or failure), Chi-square (categorical outcomes), and ROC curve analysis (diagnostic biomarker studies) are the most common.

Can PubMedico help with my DM Haematology thesis synopsis?+

Yes — PubMedico provides complete synopsis writing, statistical analysis, and results chapter support for DM and MD Haematology students. WhatsApp: +91 96642 99381 for a free consultation.